An official website of the United States government
Home
Name
Iobenguane I-131
Alternate Names
AZEDRA
Abbreviations
None
Category
Radiation
Subcategory
Radioisotope
NSC Number
None
Primary Site
None
Histology
None
Remarks
July 30, 2018: FDA approved iobenguane I 131 (AZEDRA) for adult and pediatric patients (12 years and older) with iobenguane scan-positive, unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (PPGL) who require systemic anticancer therapy.
Coding
This drug should be coded
